Prolonged recurrence-free survival, was associated with increased expression of T cell markers (CD4, CD8α, and PD-1) and elevated cleaved PARP levels in recurrent tumors, indicating enhanced anti-tumor immunity and apoptosis. This evidence concerns the gene CD8A and neoplasm.